Sacubitril/valsartan reduces indications for arrhythmic primary prevention in heart failure with reduced ejection fraction: insights from DISCOVER-ARNI, a multicenter Italian register

doi:10.1093/ehjci/jeab289.448

February 1, 2022European Heart Journal - Cardiovascular Imaging

Sacubitril/valsartan reduces indications for arrhythmic primary prevention in heart failure with reduced ejection fraction: insights from DISCOVER-ARNI, a multicenter Italian register

View at Publisher

Ask AI

Bookmark

Share

Why the study?

Does sacubitril/valsartan reduce indications for primary prevention ICD in patients with HFrEF?

Structured PICO

Does sacubitril/valsartan reduce indications for primary prevention ICD in patients with HFrEF?

P

Population

Patients with heart failure with reduced ejection fraction (HFrEF)

I

Intervention

Sacubitril/valsartan

O

Outcome

Defibrillator (ICD) indications for primary prevention

Implication

Sacubitril/valsartan may reduce the indication for primary prevention ICDs in patients with HFrEF.

Abstract

defibrillator (ICD) indications for primary prevention in heart failure with reduced ejection fraction (HFrEF) according to European guidelines indications, and its potential predictors...........

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

A 2022 study studied this question.

synapsesocial.com/papers/6a86672d9d0eab71624ca53e https://doi.org/10.1093/ehjci/jeab289.448

View at Publisher

Ask AI

Bookmark

Share

Sacubitril/valsartan reduces indications for arrhythmic primary prevention in heart failure with reduced ejection fraction: insights from DISCOVER-ARNI, a multicenter Italian register

Structured PICO

Implication

Abstract

Discussion

Cite This Study

Sacubitril/valsartan reduces indications for arrhythmic primary prevention in heart failure with reduced ejection fraction: insights from DISCOVER-ARNI, a multicenter Italian register

Structured PICO

Implication

Abstract

Discussion

Cite This Study

Keep reading

Keep reading